[CAS NO. 2172651-73-7]  RMC-4550

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [2172651-73-7]

Store
Catalog
SLK-S8718
Brand
Selleck
CAS
2172651-73-7

DESCRIPTION [2172651-73-7]

Overview

MDL-
Molecular Weight437.36
Molecular FormulaC21H26Cl2N4O2
SMILESOCC1=NC(C2=CC=CC(Cl)=C2Cl)=C(C)N=C1N(CC3)CCC43[C@H](N)[C@H](C)OC4

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM2.2864 mL11.4322 mL22.8645 mL
5 mM0.4573 mL2.2864 mL4.5729 mL
10 mM0.2286 mL1.1432 mL2.2864 mL
50 mM0.0457 mL0.2286 mL0.4573 mL

Description

RMC-4550 is a potent inhibitor with an IC50 of 1.55 nM and it has no significant activity vs. 468 kinases, the catalytic domain of 15 phosphatases and other cellular targets including GPCRs, transporters and ion channels.

Targets

SHP-2 [1]
(Cell-free assay)
1.55 nM

In vitro

RMC-4550 inhibits purified, activated full length human SHP2 with an IC50 of 1.55 nM, and has cellular IC50 of 39 nM in PC9 cells with a pERK readout. RMC-4550 has no detectable inhibitory activity up to 10 µM against the catalytic domain of SHP2, a panel of 14 additional protein phosphatases, and a panel of 468 protein kinases. RMC-4550 exhibits low to moderate cross species in vitro intrinsic clearance (3.6-24 µL/min/million cells) in hepatocytes, a high passive permeability (458 nm/s) and efflux ratio of 1.